Appendix 4D - Half Yearly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- SCENESSE successful in Phase IIa vitiligo study
- Placement
- Observations from Clinuvels US vitiligo study published
- Five month study follow up - SCENESSE in vitiligo (CUV102)
- Clinuvel clears EMA manufacturing audit
Later from Clinuvel Pharmaceuticals
All Clinuvel Pharmaceuticals news releasesFollow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals